Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

NCT00214981 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2012-07-26

No results posted yet for this study

Summary

Primary objective of this study is to evaluate the safety of treatment with modafinil film-coated tablet.

Conditions

  • Attention Deficit/Hyperactivity Disorder
  • ADHD

Interventions

DRUG

Modafinil

Sponsors & Collaborators

  • Cephalon

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00214981 on ClinicalTrials.gov